Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ...

New treatment approach shows potential in reversing lung damage caused by idiopathic pulmonary fibrosis using immune-based ...

Tulane scientists found that an FDA-approved cancer drug may help the immune system clear out damaged cells that cause lung ...

Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ..

Researchers found significant sex-based differences in ILD in patients with interdisciplinary indications for complete ...

Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.

IPF is a disease of aging and is rarely seen before age 50. These findings also offer hope that this approach could work for other similar aging related diseases.